Researchers at the University of British Columbia (UBC) found that patients taking GLP-1 drugs had a higher likelihood of developing stomach paralysis, pancreatitis, and bowel obstruction compared to individuals using bupropion-naltrexone, another weight loss medication
Findings showed that the length of ICU stay, the need for endotracheal intubation, D-dimer, LDH, ferritin, APACHE II score, and CRP in the LC group were significantly less than the control group
Feel free to consult us about any concerns related to your skin or overall health
Contact your healthcare provider if you experience: Klarity Health providers are accessible for consultation about side effect management and can help adjust your treatment plan if needed
10.1016/j.jds.2021.10.003 130 XiaW.JungJ.ShunC.XiongS.XiongL.ShiX.et al (2013)